首页 正文

Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA

{{output}}
Testing for predictive biomarkers in lung cancer has evolved to integrate immunohistochemistry, tissue-based next-generation sequencing (NGS), and liquid biopsy. Tissue-based NGS remains the foundation for comprehensive genomic profiling, enabling detection of... ...